
Strategically Navigate the Market Using Competitor Analysis in Argentina
Argentina’s business environment is shaped by economic volatility, strict import regulations, and shifting government policies. Understanding competitor strategies, pricing structures, and market positioning is crucial for businesses looking to maintain an edge. However, conducting competitor analysis in Argentina presents unique challenges, including limited data availability, high inflation impact on pricing, and complex regulatory frameworks. Without the right approach, companies risk basing decisions on unreliable or outdated information
At Midas, we help multinational companies cut through the complexity with precise, ethical, and actionable competitor analysis. Whether the goal is to refine pricing strategies, strengthen market positioning, or anticipate competitor moves, our tailored approach delivers the insights needed to drive success in Argentina
Challenges of Competitor Analysis in Argentina
Effective competitor analysis in Argentina requires navigating key obstacles, such as:
- Limited Access to Reliable Data – Market data is often outdated, inconsistent, or unavailable due to Argentina’s fragmented business environment and informal markets
- Economic Volatility and Inflation – Rapid inflation and frequent currency fluctuations make it difficult to establish stable pricing benchmarks and compare cost structures
- Regulatory and Trade Barriers – Import restrictions, government policies, and protectionist regulations create challenges in understanding how competitors source materials and operate efficiently
Without a structured, localized strategy, companies risk misinterpreting the competitive landscape, leading to ineffective pricing and market positioning decisions
How Midas Helps Overcome These Challenges
Midas provides competitor analysis solutions tailored to Argentina’s dynamic market. Our methodology ensures businesses gain valuable insights while adhering to ethical and legal best practices. Here’s how we help:
- Accurate Market Intelligence – We gather and verify data through secondary research, industry reports, and proprietary interviewing techniques to uncover insights on pricing, cost structures, and market trends
- Local Expertise and Industry Connections – Our analysts engage with key industry stakeholders, including suppliers, distributors, and market experts, to provide on-the-ground insights that go beyond publicly available information
- Strategic Recommendations for Business Growth – We translate competitor intelligence into actionable strategies, helping companies optimize pricing, adjust business models, and refine market entry approaches
Gain the Competitive Edge with Midas
With Midas, multinational companies operating in Argentina can confidently assess their competitors, identify market opportunities, and make informed decisions that drive sustainable growth.
Looking to sharpen your competitive strategy in Argentina?
Case Example: Strategic Response to Biosimilar Competition
Background and challenges
A multinational pharmaceutical company was facing the imminent expiration of patents for three of its blockbuster biologics. With multiple biosimilars in clinical trials, the company anticipated significant revenue erosion. Argentina, with its evolving regulatory framework and growing local biotech industry, posed a critical challenge in forecasting competitor moves and protecting market share
Approach
- Conducted secondary research and in-depth interviews with Argentina’s regulatory agency (ANMAT), key opinion leaders, and leading local and multinational competitors
- Assessed clinical trial progress, expected launch timelines, and potential pricing strategies of biosimilars
- Analyzed historical regulatory patterns and approval timelines to predict competitive entry scenarios
Results
With our insights, the company developed targeted defensive strategies, optimizing pricing and patient access programs. By leveraging the identified weaknesses in biosimilar launch plans, the company limited first-year sales erosion to under 10%, well below initial projections